Utah Medical Products Stock Market Value
| UTMD Stock | USD 63.73 0.47 0.73% |
| Symbol | Utah |
Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.06) | Dividend Share 1.225 | Earnings Share 3.46 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Utah Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Utah Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Utah Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Utah Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Utah Medical Products or generate 0.0% return on investment in Utah Medical over 90 days. Utah Medical is related to or competes with Nyxoah, OraSure Technologies, Repro Med, InfuSystems Holdings, Neuronetics, Perspective Therapeutics, and Protalix Biotherapeutics. Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry More
Utah Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Utah Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Utah Medical Products upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.29 | |||
| Information Ratio | 0.0699 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.94) | |||
| Potential Upside | 2.29 |
Utah Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Utah Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Utah Medical's standard deviation. In reality, there are many statistical measures that can use Utah Medical historical prices to predict the future Utah Medical's volatility.| Risk Adjusted Performance | 0.1089 | |||
| Jensen Alpha | 0.1377 | |||
| Total Risk Alpha | 0.0472 | |||
| Sortino Ratio | 0.074 | |||
| Treynor Ratio | 0.4147 |
Utah Medical February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1089 | |||
| Market Risk Adjusted Performance | 0.4247 | |||
| Mean Deviation | 1.11 | |||
| Semi Deviation | 1.11 | |||
| Downside Deviation | 1.29 | |||
| Coefficient Of Variation | 774.51 | |||
| Standard Deviation | 1.36 | |||
| Variance | 1.86 | |||
| Information Ratio | 0.0699 | |||
| Jensen Alpha | 0.1377 | |||
| Total Risk Alpha | 0.0472 | |||
| Sortino Ratio | 0.074 | |||
| Treynor Ratio | 0.4147 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.94) | |||
| Potential Upside | 2.29 | |||
| Downside Variance | 1.65 | |||
| Semi Variance | 1.23 | |||
| Expected Short fall | (1.21) | |||
| Skewness | (0.01) | |||
| Kurtosis | (0.40) |
Utah Medical Products Backtested Returns
Utah Medical appears to be very steady, given 3 months investment horizon. Utah Medical Products owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.19, which indicates the firm had a 0.19 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Utah Medical Products, which you can use to evaluate the volatility of the company. Please review Utah Medical's Risk Adjusted Performance of 0.1089, coefficient of variation of 774.51, and Semi Deviation of 1.11 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Utah Medical holds a performance score of 15. The entity has a beta of 0.4, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Utah Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Utah Medical is expected to be smaller as well. Please check Utah Medical's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether Utah Medical's existing price patterns will revert.
Auto-correlation | 0.76 |
Good predictability
Utah Medical Products has good predictability. Overlapping area represents the amount of predictability between Utah Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Utah Medical Products price movement. The serial correlation of 0.76 indicates that around 76.0% of current Utah Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.79 | |
| Residual Average | 0.0 | |
| Price Variance | 5.27 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out Utah Medical Correlation, Utah Medical Volatility and Utah Medical Performance module to complement your research on Utah Medical. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Utah Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.